SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Antemortem Underdiagnosis of Cardiac Amyloidosis in Sudden Cardiac Death Victims

Ciliberti, G; Westaby, J; Finocchiaro, G; Papadakis, M; Behr, ER; Sharma, S; Sheppard, MN (2025) Antemortem Underdiagnosis of Cardiac Amyloidosis in Sudden Cardiac Death Victims. JACC: Clinical Electrophysiology. ISSN 2405-500X https://doi.org/10.1016/j.jacep.2025.10.003
SGUL Authors: Westaby, Joseph David Papadakis, Michael

[img] PDF Accepted Version
Restricted to Repository staff only until 20 November 2026.
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (876kB)

Abstract

Background Cardiac amyloidosis is an increasingly recognized condition in clinical practice. Its role in sudden cardiac death (SCD), particularly as a first manifestation, remains poorly characterized. Objectives The goal of this study was to assess the clinical and pathologic characteristics of SCD decedents with histologically confirmed cardiac amyloidosis in a large autopsy-based registry. Methods This study reviewed 8,107 SCD cases referred to a specialist cardiac pathology center between 1994 and 2023. SCD was defined as cardiovascular death within 12 hours of apparent well-being. Histologic confirmation of cardiac amyloidosis was based on Congo red positivity and apple-green birefringence under polarized light. Clinical history and autopsy findings were analyzed. Results Cardiac amyloidosis was identified in 33 cases (0.4%), with 26 (79%) responsible for SCD. Most decedents were male (64%) with a mean age of 67 ± 18 years; 18% were aged <50 years. Coronary amyloid infiltration was significantly more frequent among decedents whose SCD was attributed to cardiac amyloidosis compared with those in whom cardiac amyloidosis was identified as an incidental finding (69% vs 14%; P = 0.026). Despite antemortem cardiac symptoms being present in 39%, only 1 patient (3%) had a known cardiac amyloidosis diagnosis before death. Conclusions Cardiac amyloidosis can be associated with SCD and is often undiagnosed during life. Coronary infiltration may contribute to SCD risk.

Item Type: Article
Additional Information: © 2025. This manuscript version is made available under the CC-BY-NC-ND 4.0 license https://creativecommons.org/licenses/by-nc-nd/4.0/
SGUL Research Institute / Research Centre: Academic Structure > Cardiovascular & Genomics Research Institute
Academic Structure > Cardiovascular & Genomics Research Institute > Clinical Cardiology
Academic Structure > Cardiovascular & Genomics Research Institute > Experimental Cardiology
Journal or Publication Title: JACC: Clinical Electrophysiology
ISSN: 2405-500X
Language: en
Publisher License: Creative Commons: Attribution-Noncommercial-No Derivative Works 4.0
Projects:
Project IDFunderFunder ID
UNSPECIFIEDCardiac Risk in the YoungUNSPECIFIED
UNSPECIFIEDNational Institute for Health and Care Researchhttps://doi.org/10.13039/501100000272
Dates:
Date Event
2025-11-20 Published Online
2025-10-14 Accepted
URI: https://openaccess.sgul.ac.uk/id/eprint/118059
Publisher's version: https://doi.org/10.1016/j.jacep.2025.10.003

Actions (login required)

Edit Item Edit Item